Lorraine Tracey

1.5k total citations
20 papers, 1.1k citations indexed

About

Lorraine Tracey is a scholar working on Cancer Research, Molecular Biology and Immunology. According to data from OpenAlex, Lorraine Tracey has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cancer Research, 7 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Lorraine Tracey's work include NF-κB Signaling Pathways (6 papers), Cutaneous lymphoproliferative disorders research (5 papers) and Neuroblastoma Research and Treatments (4 papers). Lorraine Tracey is often cited by papers focused on NF-κB Signaling Pathways (6 papers), Cutaneous lymphoproliferative disorders research (5 papers) and Neuroblastoma Research and Treatments (4 papers). Lorraine Tracey collaborates with scholars based in Spain, United States and Ireland. Lorraine Tracey's co-authors include Miguel Á. Piris, Andrew M. Davidoff, Pablo L. Ortiz‐Romero, José Luis Rodríguez‐Peralto, Raymond L. Stallings, Amanda Tivnan, Raquel Villuendas, María J. Artiga, Mark Lawler and Marina Pollán and has published in prestigious journals such as Blood, Cancer Research and Human Molecular Genetics.

In The Last Decade

Lorraine Tracey

19 papers receiving 1.1k citations

Peers

Countries citing papers authored by Lorraine Tracey

Since Specialization

Citations

This map shows the geographic impact of Lorraine Tracey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorraine Tracey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorraine Tracey more than expected).

Fields of papers citing papers by Lorraine Tracey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorraine Tracey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorraine Tracey. The network helps show where Lorraine Tracey may publish in the future.

Co-authorship network of co-authors of Lorraine Tracey

This figure shows the co-authorship network connecting the top 25 collaborators of Lorraine Tracey. A scholar is included among the top collaborators of Lorraine Tracey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorraine Tracey. Lorraine Tracey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	BMT CTN 1803: Haploidentical Natural Killer Cells (K-NK002) to Prevent Post-Transplant Relapse in AML and MDS (NK-REALM) 2021 ·Transplantation and Cellular Therapy ·Sumithira Vasu, Nelli Bejanyan, Steven M. Devine, Elizabeth O. Hexner, Brent R. Logan, Leo Luznik, Brittany Knick Ragon, (unknown), Elizabeth F. Krakow, Michael Fitzgerald, Lorraine Tracey, Richard E. Champlin	2
2	Assessing Interactions for Fixed-Dose Drug Combinations in Tumor Xenograft Studies 2012 ·Journal of Biopharmaceutical Statistics ·Jianrong Wu, Lorraine Tracey, Andrew M. Davidoff	9
3	MicroRNA-542-5p as a novel tumor suppressor in neuroblastoma 2011 ·Cancer Letters ·Isabella Bray, Amanda Tivnan, Kenneth Bryan, Niamh H. Foley, Karen M. Watters, Lorraine Tracey, Andrew M. Davidoff, Raymond L. Stallings	71
4	MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma 2011 ·BMC Cancer ·Amanda Tivnan, Lorraine Tracey, Patrick G. Buckley, Leah Alcock, Andrew M. Davidoff, Raymond L. Stallings	102
5	Tyrosine Kinase Inhibitor Gefitinib Enhances Topotecan Penetration of Gliomas 2010 ·Cancer Research ·Ángel M. Carcaboso, Mohamed Elmeliegy, Jun Shen, (unknown), (unknown), Christopher Calabrese, Lorraine Tracey, Christopher M. Waters, Clinton F. Stewart	53
6	NF-κB activation mediates resistance to IFNβ in MLL-rearranged acute lymphoblastic leukemia 2010 ·Leukemia ·Lorraine Tracey, Christian J. Streck, Zhenhua Du, Robert F. Williams, Lawrence M. Pfeffer, Amit Nathwani, Andrew M. Davidoff	14
7	MicroRNA-184-mediated inhibition of tumour growth in an orthotopic murine model of neuroblastoma. 2010 ·PubMed ·Amanda Tivnan, Niamh H. Foley, Lorraine Tracey, Andrew M. Davidoff, Raymond L. Stallings	42
8	IFN-β Restricts Tumor Growth and Sensitizes Alveolar Rhabdomyosarcoma to Ionizing Radiation 2010 ·Molecular Cancer Therapeutics ·Thomas L. Sims, (unknown), Regan F. Williams, (unknown), Lorraine Tracey, John B. Hamner, Catherine Y. Ng, Jianrong Wu, M. Waleed Gaber, M. Beth McCarville, Amit Nathwani, Andrew M. Davidoff	11
9	Maturation of tumor vasculature by interferon-beta disrupts the vascular niche of glioma stem cells. 2010 ·PubMed ·Regan F. Williams, Thomas L. Sims, Lorraine Tracey, (unknown), Catherine Y. Ng, Helen Poppleton, A C Nathwani, Andrew M. Davidoff	16
10	Psoralen plus ultraviolet A ± interferon-α treatment resistance in mycosis fungoides: the role of tumour microenvironment, nuclear transcription factor-κB and T-cell receptor pathways 2008 ·British Journal of Dermatology ·(unknown), Lorraine Tracey, Pablo L. Ortiz‐Romero, (unknown), (unknown), J. Fraga, (unknown), (unknown), José Luis Rodríguez‐Peralto, Miguel Á. Piris, Raquel Villuendas	16
11	Somatic hypermutation signature in B-cell low-grade lymphomas 2008 ·Haematologica ·Lorraine Tracey, (unknown), Mónica García‐Cosío, Raquel Villuendas, P Algara, Margarita Sánchez‐Beato, Abel Sánchez‐Aguilera, Juan F. Garcı́a, (unknown), (unknown), Nerea Martı́nez, Elena Ruíz-Ballesteros, Manuela Mollejo, Miguel Á. Piris	8
12	IFN-β sensitizes neuroblastoma to the antitumor activity of temozolomide by modulating O6-methylguanine DNA methyltransferase expression 2008 ·Molecular Cancer Therapeutics ·Shannon F. Rosati, Regan F. Williams, (unknown), (unknown), Thomas L. Sims, Lorraine Tracey, Junfang Zhou, Meiyun Fan, Catherine Y. Ng, Amit Nathwani, Clinton F. Stewart, Lawrence M. Pfeffer, Andrew M. Davidoff	17
13	A High-Throughput Study in Melanoma Identifies Epithelial-Mesenchymal Transition as a Major Determinant of Metastasis 2007 ·Cancer Research ·Soledad Alonso, Lorraine Tracey, Pablo L. Ortiz‐Romero, Beatriz Pérez‐Gómez, José Palacios, Marina Pollán, (unknown), Salvio Serrano, (unknown), Lydia Sánchez, Raquel Pajares, Abel Sánchez‐Aguilera, María J. Artiga, Miguel Á. Piris, José Luis Rodríguez‐Peralto	252
14	Expression of SMARCB1 modulates steroid sensitivity in human lymphoblastoid cells: identification of a promoter snp that alters PARP1 binding and SMARCB1 expression 2007 ·Human Molecular Genetics ·Nicolas Pottier, Meyling Cheok, Wentao Yang, Mahfoud Assem, Lorraine Tracey, (unknown), John C. Panetta, Mary V. Relling, William E. Evans	34
15	Identification of genes involved in imatinib resistance in CML: a gene-expression profiling approach 2006 ·Leukemia ·Raquel Villuendas, J. L. Steegmann, Marina Pollán, Lorraine Tracey, A Granda, Elena Fernández‐Ruiz, (unknown), Joaquín Martínez‐López, (unknown), Luís Lombardía, Lucı́a Villalón, J Odriozola, Miguel Á. Piris	84
16	Expression of the NF‐κB targets BCL2 and BIRC5/Survivin characterizes small B‐cell and aggressive B‐cell lymphomas, respectively 2005 ·The Journal of Pathology ·Lorraine Tracey, Alberto Pérez‐Rosado, María J. Artiga, Francisca I. Camacho, Antonia Rodríguez, Nerea Martı́nez, Elena Ruíz-Ballesteros, Manuela Mollejo, (unknown), Marta Cuadros, Juan F. Garcı́a, Mark Lawler, Miguel Á. Piris	119
17	Transcriptional Response of T Cells to IFN-α: Changes Induced in IFN-α-Sensitive and Resistant Cutaneous T Cell Lymphoma 2004 ·Journal of Interferon & Cytokine Research ·Lorraine Tracey, Inmaculada Spiteri, Pablo L. Ortiz‐Romero, Mark Lawler, Miguel Á. Piris, Raquel Villuendas	20
18	Posible implicación de las alteraciones moleculares de la vía de TNF en la tumorigénesis de la micosis fungoide. Descripción de un posible chip de diagnóstico molecular en micosis fungoide 2004 ·Actas Dermo-Sifiliográficas ·Lorraine Tracey, Raquel Villuendas, Ana Dotor, Inmaculada Spiteri, Juan F. Garcı́a, José Luis Rodríguez‐Peralto, F. Vanaclocha, (unknown), (unknown), De Ji, Carmen García, (unknown), Javier Fraga, (unknown), Miguel Á. Piris, Pablo L. Ortiz‐Romero	0
19	Mycosis fungoides shows concurrent deregulation of multiple genes involved in the TNF signaling pathway: an expression profile study 2003 ·Blood ·Lorraine Tracey, Raquel Villuendas, Ana Dotor, Inmaculada Spiteri, Pablo L. Ortiz‐Romero, Juan F. Garcı́a, José Luis Rodríguez‐Peralto, Mark Lawler, Miguel Á. Piris	113
20	Identification of Genes Involved in Resistance to Interferon-α in Cutaneous T-Cell Lymphoma 2002 ·American Journal Of Pathology ·Lorraine Tracey, Raquel Villuendas, Pablo L. Ortiz‐Romero, Ana Dopazo, Inmaculada Spiteri, Luís Lombardía, José Luis Rodríguez‐Peralto, Jesús Fernández‐Herrera, (unknown), Javier Fraga, Orlando Domı́nguez, Javier Herrero, Miguel A. Alonso, Joaquı́n Dopazo, Miguel Á. Piris	85

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact